“An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III Post author:Sam Post published:February 13, 2018 Post category:BioPharma Alzheimer’s drug development took another hit. Source: BioSpace You Might Also Like PPD???s Recognized For Industry Leadership August 10, 2017 Struggling Teva Loses Top R&D Exec To Eli Lilly, Novartis AG-Backed Cavion August 14, 2017 Leica Microsystems Announces Collaboration With ASM International February 5, 2017
